Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 16 Colorectal Neoplasms 7 Small Cell Lung Carcinoma 4 Neoplasm Metastasis 4 Stomach Neoplasms 3 Recurrence 3 Biliary Tract Neoplasms 3 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Ovarian Neoplasms 2 Nasopharyngeal Carcinoma 2 Fallopian Tube Neoplasms 2 Cholangiocarcinoma 2 Triple Negative Breast Neoplasms 1 Somatostatinoma 1 Solid Tumor 1 Small Cell Lung Cancer Extensive Stage 1 Small Bowel Adenocarcinoma 1 Rectal Neoplasms 1 Rectal Cancer Patients 1 Pancreatic Ductal Adenocarcinoma 1 Pancreatic Cancer Non-resectable 1 Pancreatic Cancer Metastatic to Liver 1 Pancreatic Adenocarcinoma 1 PDAC - Pancreatic Ductal Adenocarcinoma 1 Osteosarcoma 1 Neoplasms 1 Neoadjuvant Chemotherapy 1 Metastatic Pancreatic Adenocarcinoma 1 Locally Advanced Rectal Cancer (LARC) 1

Interventions

Gemcitabine 7 Albumin-Bound Paclitaxel 5 Taxes 4 Fluorouracil 4 dehydroftorafur 3 Radiotherapy 3 Oxaliplatin 3 Radiotherapy, Intensity-Modulated 2 Losartan 2 Leucovorin 2 Irinotecan 2 130-nm albumin-bound paclitaxel 2 irinotecan sucrosofate 1 indusatumab 1 X-Rays 1 Surgical Procedures, Operative 1 Specimen Handling 1 S 1 (combination) 1 Radiotherapy, Image-Guided 1 Radiation 1 Pancreatectomy 1 Folfox protocol 1 Erlotinib Hydrochloride 1 Cetuximab 1 Capecitabine 1 Anesthesia, General 1 Anesthesia 1 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Pancreatic Adenocarcinoma × irinotecan sucrosofate × Clear all

NCT03528785 2021-08-02

nITRo

Centro Ricerche Cliniche di Verona

Phase 2 Unknown

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡